Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Alzheimer’s Disease

neocortex1 - synthetic tau fibrils1 - brain health1 - physical function1 - ftld4 - alzheimer's plaques1 - early alzheimer's disease1 - lafora1 - cerebrovascular disease1 - memory retrieval1 - dopamine6 - bonfiglio1 - parkinson's drug2 - fuller1 - gammagard1 - risk for dementia1 - mmse1 - alzheimer's causes1 - quality standards subcommittee1 - alzheimer type2 - normal aging1 - neuroanatomical changes1 - phosphorylated tau1 - wernicke encephalopathy2 - brain damage2 - dementias first signs1 - alzheimer society1 - wks4 - memory disorder1 - mri scan1 -